Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
+$1.14B |
| 2 |
AbbVie
ABBV
|
+$537M |
| 3 |
T-Mobile US
TMUS
|
+$504M |
| 4 |
Baidu
BIDU
|
+$474M |
| 5 |
Kroger
KR
|
+$448M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.32B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$504M |
| 5 |
Humana
HUM
|
+$466M |
Sector Composition
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.11% |
| 3 | Consumer Staples | 10.59% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCHB
1026
Mechanics Bancorp Class A Common Stock
MCHB
$2.96B
| $13.9M | 0.01% |
565,100
-2,600
| -0.5% | -$64K |
|
1027
Copel
ELP
$6.84B
| $13.9M | 0.01% |
3,060,250
-2,093,250
| -41% | -$9.51M |
|
1028
DURECT Corp
DRRX
$59.3M
| $13.9M | 0.01% |
598,970
+78,149
| +15% | +$1.81M |
|
1029
West Pharmaceutical
WST
$18.4B
| $13.9M | 0.01% |
61,100
-304,100
| -83% | -$69.1M |
|
1030
Hilltop Holdings
HTH
$2.19B
| $13.9M | 0.01% |
751,000
-200,384
| -21% | -$3.7M |
|
|
MNTA
1031
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $13.8M | 0.01% |
416,251
+359,237
| +630% | +$12M |
|
1032
NiSource
NI
$19.2B
| $13.8M | 0.01% |
607,300
-1,234,631
| -67% | -$28.1M |
|
1033
AptarGroup
ATR
$8.98B
| $13.8M | 0.01% |
123,300
+95,200
| +339% | +$10.7M |
|
|
ZIXI
1034
DELISTED
Zix Corporation
ZIXI
| $13.8M | 0.01% |
1,999,094
-509,100
| -20% | -$3.51M |
|
|
EVRI
1035
DELISTED
Everi Holdings
EVRI
| $13.7M | 0.01% |
2,662,500
-274,600
| -9% | -$1.42M |
|
1036
SunCoke Energy
SXC
$656M
| $13.7M | 0.01% |
4,640,433
-600,318
| -11% | -$1.78M |
|
1037
Oil-Dri
ODC
$960M
| $13.7M | 0.01% |
791,492
+31,800
| +4% | +$552K |
|
1038
Landstar System
LSTR
$4.5B
| $13.7M | 0.01% |
122,240
+37,700
| +45% | +$4.23M |
|
|
MIME
1039
DELISTED
Mimecast Limited
MIME
| $13.7M | 0.01% |
329,400
+291,200
| +762% | +$12.1M |
|
|
UBA
1040
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $13.7M | 0.01% |
1,155,022
-266,900
| -19% | -$3.17M |
|
1041
MEI Pharma
MEIP
$101M
| $13.7M | 0.01% |
165,624
+12,515
| +8% | +$1.03M |
|
|
CNBKA
1042
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $13.6M | 0.01% |
175,603
-4,998
| -3% | -$388K |
|
|
LGF.A
1043
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $13.6M | 0.01% |
1,841,678
-102,100
| -5% | -$757K |
|
1044
Deluxe
DLX
$858M
| $13.6M | 0.01% |
578,310
+96,000
| +20% | +$2.26M |
|
1045
TriMas Corp
TRS
$1.56B
| $13.6M | 0.01% |
568,270
-7,200
| -1% | -$172K |
|
1046
Kemper
KMPR
$3.32B
| $13.6M | 0.01% |
187,236
-39,900
| -18% | -$2.89M |
|
1047
Ironwood Pharmaceuticals
IRWD
$187M
| $13.6M | 0.01% |
1,313,853
-184,600
| -12% | -$1.91M |
|
1048
Nathan's Famous
NATH
$437M
| $13.5M | 0.01% |
240,820
-3,500
| -1% | -$197K |
|
|
AMED
1049
DELISTED
Amedisys
AMED
| $13.5M | 0.01% |
68,201
-100,500
| -60% | -$20M |
|
1050
Agilysys
AGYS
$3.03B
| $13.5M | 0.01% |
753,552
+92,903
| +14% | +$1.67M |
|